Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NJOY e-cigarette in smokers with COPD
NCT05239793Phase 1Active, not recruiting
- Sponsor
- Penn State Health Milton S. Hershey Medical Center
- Start
- Nov 2022
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of NJOY in chronic obstructive pulmonary disease (COPD), sponsored by Penn State Health Milton S. Hershey Medical Center. Primary endpoints: Cigarettes per day at 3 months and Number of exacerbations at 3 months. Started Nov 2022; status: active, not recruiting.
02
Drugs
NJOY
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT05239793.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05239793.